Hemodiafiltration method

Patent metadata

Field	Value
Publication number	US-10172994-B2
Application number	US-201314654711-A
Country	US
Kind code	B2
Filing date	Dec 19, 2013
Priority date	Dec 20, 2012
Publication date	Jan 8, 2019
Grant date	Jan 8, 2019

Abstract

The invention relates to a device for hemodiafiltration with an extracorporeal circulation (10) for receiving blood to be purified and having a hemodialyzer and/or hemofilter (20) which is connected to the blood circulation (10), such that the blood circulation (10) has at least one inlet line (12, 14) for the supply of a replacement fluid upstream and downstream from the hemodialyzer and/or hemofilter (20), characterized in that the apparatus also comprises measurement apparatuses for recording the transmembrane pressure and/or hematocrit (HKT) and/or blood density, such that the measurement apparatuses are connected to a control unit (100) for controlling one or more of the transmembrane pressure and/or the hematocrit (HKT) and/or the blood density, the control unit (100) being constructed so that the control is implemented with the help of at least one of the infusion rates (Qspre, Qspost) of the replacement fluid (13, 15), and the blood to be purified is exposed to a high-frequency electromagnetic field and/or an electric DC field (70) before and/or during contact with the hemodialyzer and/or hemofilter (20).

First claim

The invention claimed is:

1. A hemodiafiltration device comprising:
a hemodialyzer/hemofilter separated by a membrane into a blood circulation chamber and dialysis fluid circulation chamber;
an extracorporeal blood circulation line extending upstream and downstream of the blood circulation chamber and having at least one replacement-fluid inlet line upstream and at least one replacement-fluid inlet line downstream of said blood circulation chamber;
at least one measurement apparatus for recording at least one of transmembrane pressure, difference between upstream and downstream hematocrit (HKT), and difference between upstream and downstream blood density;
a control unit connected to the at least one measurement apparatus and constructed for control of at least one of the transmembrane pressure, the hematocrit, and the blood density by controlling the upstream and downstream infusion rates of the replacement fluid (Q s pre, Q s post) based on input received from the at least one measurement apparatus; and
a high-frequency electromagnetic field generator configured to generate a field having a frequency of 1 MHz to 1 GHz arranged to surround the hemodialyzer/hemofilter or a part of the extracorporeal blood circulation line extending upstream of the hemodialyzer/hemofilter and the hemodialyzer/hemofilter in order to expose blood during or before an during passing through the blood circulation chamber to a high-frequency electromagnetic field.

2. The device according to claim 1 further comprising
f) a dialysis fluid circulation line extending upstream and downstream of the dialysis fluid circulation chamber, and
g) pressure sensors arranged in the dialysis fluid circulation line upstream and downstream of the dialysis fluid circulation chamber, respectively.

3. The device according to claim 1 , wherein the control unit is configured to control the infusion rates (Q s pre, Q s post) of the replacement fluid so that Q s pre is greater than or equal to Q s post during hemodiafiltration treatment.

4. The device according to claim 1 , wherein the control unit is configured to control the infusion rates (Q s pre, Q s post) of the replacement fluid so that the ratio of the infusion rates Q s pre/Q s post is at least 1.2.

5. The device according to claim 1 , wherein the control unit is configured to control the infusion rates (Q s pre, Q s post) of the replacement fluid so that the ratio of the infusion rates Q s pre/Q s post is at least 1.5.

6. The device according to claim 1 , wherein the high-frequency electromagnetic field generator is a high-frequency coil, a high-frequency electrode, or a high-frequency capacitor.

7. The device according to claim 1 , wherein the high-frequency electromagnetic field generator has an output power greater than −12 Db.

8. The device according to claim 1 , wherein the high-frequency electromagnetic field generator is configured to generate a field having a frequency of 10 MHz-1 GHz.

9. The device according to claim 1 , wherein the high-frequency electromagnetic field generator is configured to generate a field having a frequency of 20 MHz-1 GHz.

Assignees

• Fresenius Medical Care Deutschland Gmbh

Inventors

• Tschulena Ulrich
• Jankowski Joachim
• Fabig Anselm
• Mueller Carsten

Classifications

• A61M1/3403

  Regulation parameters · CPC title

• A61M1/3639 Primary

  Blood pressure control, pressure transducers specially adapted therefor · CPC title

• A61M1/3681

  by irradiation · CPC title

• A61M2230/207

  hematocrit · CPC title

• A61M2202/0445

  Proteins · CPC title